BioSpace News Archive

Veru Inc. today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present at the upcoming Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 11 a.m. ET.

Thermo Fisher Scientific Inc. hosted its 2023 Investor Day today and provided an in-depth review of the Company’s proven growth strategy and its industry-leading businesses.

RenovoRx, Inc today announced that Shaun Bagai, CEO, will present at the 13th Annual LD Micro Invitational, held on June 6-8, 2023 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2023 AACC and AACC Academy Awards.

TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) is proud to announce it will be presenting at the LD Micro Invitational XIII Conference being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA June 6 - 8, 2023.

Clarity Pharmaceuticals is pleased to announce the completion of cohort 1 and advancement to cohort 2 in the therapeutic phase of its Phase I/II theranostic trial, SECuRE, evaluating 64Cu/67Cu SAR-bisPSMA in patients with mCRPC.

BioCentriq® announced today that CEO of BioCentriq, Haro Hartounian, Ph.D. will be presenting at the International Society for Cell & Gene Therapy (ISCT) 29th annual event taking place at the Paris Convention Center in Paris, France May 31 - June 3, 2023.

Dompé farmaceutici announced today new peer-reviewed data demonstrating that small changes in the SARS-CoV-2 Spike (S)-protein sequence can eliminate its effect in inducing coagulation.

Curative Biotechnology Inc. announced that a Patent Cooperation Treaty application was duly filed in the U.S. Receiving Office on May 22, 2023, claiming priority to U.S. Provisional Application No. 63/345,759, filed May 25, 2022.

Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW)—and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) defining COVID-19 vaccine response in allogeneic hematopoietic cell transplantation (HCT) were recently published in eClinicalMedicine.